This randomized controlled trial evaluated a structured Team STEPPS-based discharge planning program in 90 inpatients with inflammatory bowel disease in a hospital setting. Participants were assigned to the intervention or to standard care, with outcomes assessed during a 30-day follow-up period.
The primary outcome, discharge readiness, was significantly higher in the intervention group (103.0 ± 7.3) than in the control group (94.9 ± 4.7; P < 0.001). The quality of discharge teaching was also significantly higher in the intervention group (183.6 ± 6.4) compared with control (172.7 ± 5.0; P < 0.001). For health-related quality of life, the intervention group demonstrated a greater magnitude of improvement, with an incremental benefit of 9.2 points (95% CI: 5.7–12.7; P < 0.001).
Adverse events, serious adverse events, discontinuations, and overall tolerability were not reported. The study was conducted in a single hospital, which may limit generalizability. Practice relevance and funding or conflicts were not reported.
While the results are statistically significant, they derive from a single-center trial. Clinicians should interpret these findings as promising evidence that a Team STEPPS-based discharge program may enhance readiness and quality of life, with confirmation in larger, multicenter studies needed before widespread adoption.
View Original Abstract ↓
BackgroundThe transition from hospital to home is a high-risk period for patients with Inflammatory Bowel Disease (IBD). This study aimed to develop and preliminarily validate a structured discharge planning program for patients with IBD by applying the Team STEPPS framework.MethodsThis study employed a sequential two-phase, mixed-methods design. First, a Team STEPPS-based discharge planning program was rigorously developed using Delphi method between August and October 2023. Subsequently, a randomized controlled trial was conducted from October 2023 to March 2024 to validate the program. Ninety eligible inpatients were randomly assigned to an intervention group (n = 45) receiving the structured Team STEPPS program or a control group (n = 45) receiving standard care. The primary outcome was discharge readiness, assessed at the time of discharge. Secondary outcomes included the quality of discharge teaching, measured at discharge, and health-related quality of life, evaluated at baseline, discharge, and 30-day follow-up. Longitudinal outcomes analyzed via linear mixed-effects models.ResultsAll 90 enrolled participants completed the study. The Delphi process successfully achieved expert consensus, resulting in a structured discharge program with all items meeting predefined criteria (mean importance ≥ 4.0, coefficient of variation ≤ 0.25). In the subsequent randomized controlled trial, baseline characteristics were well-balanced. At discharge, the intervention group exhibited statistically superior outcomes, including significantly higher discharge readiness (103.0 ± 7.3 vs. 94.9 ± 4.7, P < 0.001) and quality of discharge teaching scores (183.6 ± 6.4 vs. 172.7 ± 5.0, P < 0.001). Longitudinal analysis of health-related quality of life revealed a significant group-by-time interaction effect (P < 0.001), with the intervention group demonstrating a greater magnitude of improvement. The model estimated an incremental benefit of the intervention of 9.2 points (95% CI: 5.7–12.7) at the 30-day follow-up compared to standard care.ConclusionA Team STEPPS-based discharge planning program was successfully developed and shown to be effective, significantly improving discharge readiness, the quality of discharge teaching, and health-related quality of life in patients with IBD.Clinical trial registrationhttps://www.chictr.org.cn/index.html, identifier ChiCTR2501113716.